טוען...
Response to Tenofovir Among Lamivudine-Experienced Hepatitis B and HIV Coinfected Adolescents
We determined hepatitis B virus (HBV) suppression rates among 18 lamivudine (3TC)-experienced HBV-HIV coinfected adolescents after treatment with tenofovir disoproxil fumurate (TDF). At TDF initiation, their median age was 17.6 years, and duration of 3TC-exposure was 7.3 years. Eleven patients (61%)...
שמור ב:
| הוצא לאור ב: | Pediatr Infect Dis J |
|---|---|
| Main Authors: | , , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2017
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5348266/ https://ncbi.nlm.nih.gov/pubmed/28005687 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/INF.0000000000001491 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|